Belgium· BE-AMP-SAM553057-00
Qtrilmet 1000 mg - 2.5 mg - 5 mg
A metformin, saxagliptin and dapagliflozin product containing dapagliflozin propanediol monohydrate, registered in Belgium by AstraZeneca. The same ATC class is registered in 2 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Metformin, saxagliptin and dapagliflozin is registered in 2 of 19 countries.
Countries holding a registration under ATC A10BD25 (metformin, saxagliptin and dapagliflozin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 2 of them publish a price we can compare per daily dose
Metformin, saxagliptin and dapagliflozin · ATC A10BD25
2 / 19 countries
- Belgiumprice
- Finlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Dapagliflozin Propanediol Monohydrate
- Manufacturer
- AstraZeneca
- Country
- Belgium (BE)
- ATC code
- A10BD25
- ATC class
- Metformin, saxagliptin and dapagliflozin
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Metformin, saxagliptin and dapagliflozin in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDAGETIAPharmaPath S.A., Agia Varvara
- United StatesDAPAGLIFLOZINCipla USA Inc.
- FinlandDapagliflozin KrkaKRKA d.d. Novo mesto
- IrelandDapagliflozin Clonmel 10 mg film-coated tabletsClonmel Healthcare Ltd
- GermanyDapagliflozin CiplaCipla Europe Nv
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Austria · Dapagliflozin Denk
- Germany · Dapagliflozin Cipla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c1b4d4bc-5568-4ba3-8e34-06de4550c0c0 GET /v1/drugs/c1b4d4bc-5568-4ba3-8e34-06de4550c0c0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Modified-release tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Qtrilmet 1000 mg - 2.5 mg - 5 mg",
"name_fr": "Qtrilmet 1000 mg - 2.5 mg - 5 mg",
"name_nl": "Qtrilmet 1000 mg - 2.5 mg - 5 mg",
"amp_code": "SAM553057-00",
"strengths": [
"1000.0000",
"5.0000",
"2.5000",
"5.0000",
"1000.0000",
"2.5000",
"2.5000"
],
"pack_count": 14,
"substances": [
"Dapagliflozin Propanediol Monohydrate",
"Metformin Hydrochloride",
"Dapagliflozin",
"Saxagliptin Hydrochloride",
"Saxagliptin"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Metformin, Saxagliptin and Dapagliflozin",
"authorisation_numbers": [
"EU/1/19/1401/016",
"EU/1/19/1401/017",
"EU/1/19/1401/015",
"EU/1/19/1401/020",
"EU/1/19/1401/021",
"EU/1/19/1401/018",
"EU/1/19/1401/019",
"EU/1/19/1401/024",
"EU/1/19/1401/025",
"EU/1/19/1401/022",
"EU/1/19/1401/023",
"EU/1/19/1401/028",
"EU/1/19/1401/026",
"EU/1/19/1401/027"
]
}See everything about metformin, saxagliptin and dapagliflozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.